Product Description
RapaPro (Rapamycin Tablets 1 mg) contains Sirolimus, an immunosuppressive agent formulated using advanced nanoparticle technology to enhance solubility and improve oral bioavailability. Each film-coated tablet provides 1 mg of Sirolimus and is intended for oral administration.
Sirolimus works by inhibiting the mammalian target of rapamycin (mTOR) pathway, thereby suppressing T-lymphocyte activation and proliferation. This action helps prevent organ transplant rejection and regulates immune responses. The nanoparticle formulation ensures consistent drug absorption and reliable therapeutic performance.
RapaPro is primarily indicated for the prophylaxis of organ rejection in renal (kidney) transplant recipients, generally in combination with other immunosuppressive agents such as corticosteroids and calcineurin inhibitors, as directed by the treating physician. It may also be prescribed for other approved indications based on clinical judgment and local treatment guidelines.
Manufactured under stringent quality standards, RapaPro film-coated tablets are designed to provide consistent potency, stability, and efficacy. Treatment with Sirolimus requires regular monitoring of blood drug concentrations, renal function, liver function, lipid profile, and complete blood counts to ensure optimal therapeutic outcomes and minimize adverse effects.
Comprehensive Dosage GuidelinesThe initial recommended dose for RAPAPRO TABLETS is 6 mg taken orally, followed by a daily maintenance dose of 2 mg or as directed by your physician. As the dosage may need to be tailored according to individual patient needs, always adhere strictly to your healthcare provider's guidance. Taking the tablets with warm water ensures better absorption and effectiveness.
Proper Storage Ensures PotencyTo preserve the integrity of RAPAPRO TABLETS, store them in a cool and dry environment, away from direct sunlight and moisture. The plastic box packaging offers additional protection, ensuring each dose retains its intended potency. Avoid keeping the tablets in humid places like bathrooms or near kitchen sinks.
Intended Use and BenefitsRAPAPRO TABLETS are formulated to aid adults and elderly individuals undergoing renal transplantation. As part of an immunosuppressive therapy, they help prevent organ rejection, thereby increasing the success rate of kidney transplants. The main benefit is derived from its ability to modulate the immune response efficiently.
FAQ's of RAPAPRO TABLETS:
Q: How should RAPAPRO TABLETS be taken for optimal results?
A: RAPAPRO TABLETS should be taken exactly as prescribed by your transplant specialist, typically with warm water. Adhering to the initial loading dose and subsequent maintenance dose is essential for optimal protection against organ rejection.
Q: What is the recommended dosage for RAPAPRO TABLETS?
A: The suggested initial loading dose is 6 mg orally, followed by a maintenance dose of 2 mg once daily. Your physician may adjust these doses depending on your individual requirements and health status.
Q: When should RAPAPRO TABLETS be used in a transplant regimen?
A: RAPAPRO TABLETS are incorporated at the onset of immunosuppressive therapy in adult kidney transplant recipients, as determined by a qualified healthcare provider.
Q: Where should RAPAPRO TABLETS be stored to ensure their potency?
A: Store the tablets in a cool and dry place, away from heat, moisture, and direct sunlight. Keeping them in their original plastic box packaging protects against environmental factors.
Q: What process does RAPAPRO TABLETS undergo in your body?
A: RAPAPRO TABLETS work by suppressing the immune response, thereby reducing the risk of kidney transplant rejection. Regular, prescribed intake is vital to maintain the correct balance of immunosuppression.
Q: Who is RAPAPRO TABLETS suitable for?
A: These tablets are suitable for adult and elderly patients who have received a kidney transplant and are undergoing immunosuppressive therapy as part of their treatment plan.
Q: What are the benefits of using RAPAPRO TABLETS after renal transplantation?
A: RAPAPRO TABLETS help prevent organ rejection, enhancing the long-term success and survival of the transplanted kidney. Their tailored dosing ensures effective immunosuppression while accommodating individual patient needs.